Stay updated on Adagrasib with Nab-Sirolimus in KRAS G12C NSCLC Clinical Trial

Sign up to get notified when there's something new on the Adagrasib with Nab-Sirolimus in KRAS G12C NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adagrasib with Nab-Sirolimus in KRAS G12C NSCLC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and v3.4.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T17:39:28.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1. No user-facing content or functionality appears affected.
    Difference
    0.1%
    Check dated 2026-02-06T11:35:19.000Z thumbnail image
  4. Check
    19 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1, a minor version change that does not affect study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T13:27:53.000Z thumbnail image
  5. Check
    27 days ago
    Change Detected
    Summary
    UI changes include showing the glossary and updating QC/version-related labels on the study record; these updates do not alter trial data, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-29T06:18:59.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The page shows Revision: v3.3.4 in place of Revision: v3.3.3, indicating a small internal update to the site's software.
    Difference
    0.1%
    Check dated 2026-01-15T03:00:51.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    A dedicated Locations section was added with sites in Ohio, Tennessee, and Texas, and the previous separate location entries were removed.
    Difference
    0.5%
    Check dated 2025-12-24T16:29:13.000Z thumbnail image

Stay in the know with updates to Adagrasib with Nab-Sirolimus in KRAS G12C NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adagrasib with Nab-Sirolimus in KRAS G12C NSCLC Clinical Trial page.